Fuente CA, Giampapa CV, Ramírez O

Language: Spanish
References: 23
Page: 35-39
PDF size: 64.56 Kb.

ABSTRACT

For the first time we can look at the ageing process with a new perspective, treating it not only as surgeons operating on the external effects, but also as doctors helping to reverse the effects of ageing. In this paper the four main processes: glycation, inflammation, oxidation and methylation are described as well as the chemical and biological relationships between them. The changes caused by the ageing process in the different areas of the economy, as well as the surgical procedures for their restoration and the measures anti-ageing medicine recommends to prevent them are described. Integrating the practice of this new area of medicine to our specialty, plastic surgery will be the only specialty that will be able to prevent or delay the ageing process and to correct the external alterations it causes.

REFERENCES

1. Bland J. Improving genetic expression in the prevention of the diseases of aging. Health Commu. Seminar Series, 1998.

2. Cerami A. Hypothesis: Glucose as mediator of aging. JAM Gerontology Soc 1985; 23: 626-634.

3. Mark P. Understanding the natural management of pain and inflammation. Clinical nutrition insights, advanced nutrition insights, 1998.

4. Horrobin DF. Loss of delta 6-desaturase activity as a key factor in aging. Med Hypothesis 1981; 7: 1211-1220.

5. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad Biol Med 1991; 10: 339-352.

6. McCarleyís KS. The hemocysteine revolution, new Caanan. C-T Keats, Pub. Inc. 1997

7. Rucker R, Tinker D. The role of nutrition in gene expression: a fertile field for the application of molecular biology. F Nutr 1986; 116: 177-189.

8. Berdanier CD. Nutrition and genetic diseases. In: Nutrients and gene expression, Berdanier CD, Hargrove JL. Boca Raton: CRC Press. 1996: 1-20.

9. Goodman, J. Histone tails way the DNA dog, Helix, University of VA, Health System, Volume 17, Spring 2000.

10. Giampapa V, DiBernardo B, Park C. Advances in anti-aging medicine. Vol. 1, Mary Ann Liebert, Publishers Inc., NY, NY 1996; 57-60.

11. Yanick P, Giampapa V. Quantum Longevity. Chapter 5. 55-76. Promotion Publishing. San Diego, CA, 1997.

12. Reaven G. Pathophysiology of insulin resistance in human disease. Physiological Reviews. 1995; 75(3): 473-485.

13. Tong P, Thomas T, Berrish T et al. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet 1995; 345: 357-358.

14. Lukacser ND. Functional medicine adjunctive nutritional surpport for sindrome X. Health Comm Int. Inc., Gig Harbor, WA, 1998.

15. Shippen E, Fryer W. The testosterone syndrome. M. Evans & Co., Inc., NY, NY 1998. 190.

16. Shippen E, Fryer W. The testosterone syndrome. M. Evans & Co., Inc., NY, NY 1998. 190.

17. Reaven G. Role of insulin resistance in human disease. Diabetes 1998; 37: 1495-1507.

18. Miyata T, Hori O, Zhang JH et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-B2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. F Clin Invest 1996; 98(5): 1088-1094.

19. Iehara N, Takeoka H, Yamada Y, Kita T, Doi T. Advanced glycation end products modulate transcriptional regulation in mesangial cells. Kidney Int 1996; 50(4): 1166-1172.

20. Sapolsky RM et al. The Neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis.

21. Yanick P, Giampapa VC. Quantum longevity. Promotion Publishing, San Diego, USA, 1997.

22. Gonzalez AJ. Manual de autocuidado y salud en el envejecimiento. Costa-Amic Edit., México. 6ª edic., 1999.

23. Colgan M. Hormonal health. Apple Publishing, Vancouver, Canada, 1996.